Clinical Trials › NCT07224373
RecruitingPhase 1
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
Sponsored by AstraZeneca
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 24
Target enrollment
8
U.S. states
Dec 2025
Start date
Dec 2028
Expected completion
Interventions / Treatments
AZD0120 - Regimen 1AZD0120 - Regimen 2
Conditions studied
Multiple Sclerosis
Where this trial is running (9 sites)
New York2 sites
New York · New York
Arizona1 site
Tucson
Colorado1 site
Aurora
District of Columbia1 site
Washington D.C.
Missouri1 site
St Louis
Ohio1 site
Cleveland
Washington1 site
Seattle
Wisconsin1 site
Milwaukee
Participating MS centers on MS Buddy (1)
MS centers in New York
Compare treatment centers near a trial site by center type, providers and trials.
View New York centersMore Phase 1 trials
Browse all Phase 1 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.